Under- and overweight generics drive recalls

Weight problems are driving recalls of generic products. In recent Teva recalls, both metronidazole tablets and gabapentin capsules are underweight, while overweight tablets have saddled Caraco, Ethex and Actavis Totowa with recall actions over the past two years.

For Teva, the one-lot metronidazole callback affects sufferers of the STD trichomoniasis in the U.S. The four-batch recall of seizure treatment gabapentin affects the U.K.

The Activis 2008 recall involved the heart drug Digitek (digoxin) for pills that could contain twice the approved level of API. Caraco also recalled digoxin. An Ethex recall involved oversized morphine tablets, reports AboutLawsuits.com.

The Teva metronidazole lot is packaged in 250 count bottles and was distributed nationwide to wholesalers and retailers, who were notified of the recall in late October. Gabapentin underwent a class 2 recall, requiring action within 48 hours and quarantining of the product, in late December.

- see the story
- here's the metronidazole recall notice
- and the gabapentin notice


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.